# Zevra Therapeutics, Inc.: Form 8-K, filed Dec 6, 2024

- Company: [Zevra Therapeutics, Inc.](/companies/zvra.md) (CIK 1434647)
- Form: 8-K
- Filed: 2024-12-06
- Accepted by EDGAR: Dec 6, 2024, 17:28 ET
- Period: 2024-12-02
- Accession: 0001437749-24-036876
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434647/000143774924036876/zvra20241204_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434647/000143774924036876/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434647/000143774924036876/zvra20241204_8k.htm

Filed Dec 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-036876. Last ingested by Listed: Nov 5, 2026, 14:04 ET. No prices; not investment advice.